What Are the Most Common Digestive System Diseases?

Functional gastrointestinal disorders, particularly irritable bowel syndrome and functional dyspepsia, top the list by sheer numbers. A multinational survey of more than 73,000 adults found that roughly one in five to two in five people met the diagnostic criteria for at least one functional gut disorder, depending on how the data were collected.¹ Behind those sit a long roster of structural and inflammatory conditions, from acid reflux and peptic ulcers to gallstones, liver disease, hemorrhoids, and inflammatory bowel disease, each affecting tens of millions of people worldwide. Understanding which digestive diseases are most widespread matters because the symptoms overlap heavily and the risk factors are often modifiable.

The Global Burden of Digestive Disease

Digestive diseases collectively accounted for about 89 million disability-adjusted life years (a measure combining years lost to premature death and years lived with disability) in 2019, making them the 13th leading cause of health loss worldwide.² The good news is that the age-adjusted burden has been falling: rates dropped by about 30% between 1990 and 2019. The bad news is that modifiable risk factors still drive a huge share of the damage. In 2021, preventable causes accounted for more than 40% of all digestive disease deaths and disability globally, with alcohol use as the single largest contributor.³ Cirrhosis and other chronic liver diseases made up the largest slice of that burden.²

Men carry a heavier burden than women for most structural and liver-related digestive diseases, while women are more likely to develop functional disorders like IBS and functional dyspepsia.¹ Geography matters too: middle-income countries and South Asia bear a disproportionate share of digestive disease disability.²

Irritable Bowel Syndrome and Functional Dyspepsia

IBS and functional dyspepsia are the two most common functional gastrointestinal disorders. “Functional” means diagnostic tests like endoscopy and imaging come back normal; the problem lies in how the gut behaves rather than in visible structural damage. The Rome Foundation global study found that functional disorders were more common in women, with the odds roughly 1.3 to 1.7 times higher depending on the survey method.¹ People with these conditions report lower quality of life and visit the doctor more often than those without them.

IBS involves chronic abdominal pain tied to changes in bowel habits, whether diarrhea, constipation, or a mix. One increasingly studied driver is the communication loop between the brain and the gut, often called the gut-brain axis. The trillions of microbes living in the intestines talk to the nervous system through hormonal and neural signals, and disruptions in that conversation appear central to how IBS develops and persists.⁴

Functional dyspepsia centers on the upper stomach: pain or burning in the upper abdomen, uncomfortable fullness after meals, and early satiety. It shares substantial overlap with gastroparesis, a condition where the stomach empties too slowly. Both involve abnormal stomach movement, heightened sensitivity to normal sensations, and mucosal inflammation, and their symptoms can be nearly identical.⁵ In practice, a gastric emptying study sometimes distinguishes the two, but even that line is blurry because slow emptying does not correlate well with symptom severity.⁶

Gastroesophageal Reflux Disease and Peptic Ulcers

GERD, the chronic backwash of stomach acid into the esophagus, is one of the most recognized digestive conditions. It causes heartburn and regurgitation and, over years, can lead to Barrett’s esophagus, a precancerous change in the esophageal lining. The risk of Barrett’s is highest in people whose reflux symptoms started young: those who began having weekly heartburn before age 30 had roughly 15 times the odds of developing Barrett’s compared to people whose symptoms started later.⁷ This makes early and persistent reflux a red flag worth mentioning to a doctor.

Peptic ulcer disease, meaning sores in the lining of the stomach or the first part of the small intestine, has two dominant causes. The bacterium Helicobacter pylori and the use of nonsteroidal anti-inflammatory drugs (NSAIDs like ibuprofen or aspirin) each independently raise the risk, and when both are present, they interact synergistically to make ulcers much more likely.⁸ Testing for and treating H. pylori is especially important in people who need to take NSAIDs regularly.⁹

Inflammatory Bowel Disease

Crohn’s disease and ulcerative colitis are the two main forms of inflammatory bowel disease (IBD). They share some surface similarities, including chronic diarrhea, abdominal pain, and fatigue, but their underlying biology is distinct. Crohn’s can affect any part of the digestive tract and penetrate deep into the tissue, while ulcerative colitis is limited to the colon and rectum and stays in the superficial lining. The immune pathways also differ: Crohn’s is driven primarily by defects in the innate immune system and by certain signaling molecules, whereas ulcerative colitis involves a different set of immune cells and genetic mutations.¹⁰ Even the gut microbiome profiles of the two diseases differ, meaning each condition fosters a distinct microbial environment.

Why this matters practically: because the biology diverges, treatments that work well for one form of IBD may not help the other. Research into these distinct pathways is opening doors to more targeted therapies rather than blanket immune suppression.

Diverticular Disease and Hemorrhoids

Diverticulosis, the formation of small pouches in the colon wall, is the most frequently detected structural finding during colonoscopy.¹¹ Most people with diverticula never know they have them. A subset develop diverticulitis, where one or more pouches become inflamed or infected, causing sharp abdominal pain, fever, and changes in bowel habits. Prevalence climbs steeply with age, especially after 65, though recent data show it is increasing among adults over 40 as well. Smoking, obesity, alcohol use, and a low-fiber diet all raise the risk.¹¹

Hemorrhoids are another extraordinarily common condition, though people rarely volunteer the information. Global prevalence estimates range wildly, from about 4% to well over a third of the adult population depending on the country and how the surveys are done.¹² Hemorrhoids develop when the cushions of tissue in the anal canal swell and shift out of position, often from chronic straining during bowel movements.¹³ Constipation and hemorrhoids are tightly linked: people with hemorrhoids are about twice as likely to have functional constipation compared to the general population, and their baseline anal pressures tend to be higher.¹⁴ Addressing constipation, through fiber, hydration, and avoiding prolonged straining, is a first-line strategy for both preventing and managing hemorrhoids.

Celiac Disease

Celiac disease is an autoimmune disorder triggered by gluten, the protein found in wheat, rye, and barley.¹⁵ In genetically susceptible people, eating gluten sets off an immune reaction that damages the lining of the small intestine, leading to diarrhea, abdominal pain, and poor nutrient absorption. Diagnosis typically relies on a combination of blood tests for specific antibodies, a biopsy of the small intestine showing characteristic damage, and improvement on a gluten-free diet.¹⁶

A persistent misconception is that celiac disease and gluten sensitivity are the same thing. They are not. Celiac disease involves a measurable autoimmune response with intestinal damage and carries long-term health risks if untreated. Non-celiac gluten sensitivity produces some overlapping symptoms but does not cause the same intestinal destruction or autoimmune markers. The distinction matters because celiac disease requires lifelong strict gluten avoidance, whereas the management of non-celiac sensitivity is less clear-cut.

Gallstones

Gallstones form inside the gallbladder, and the vast majority are cholesterol-based. The process involves bile that becomes oversaturated with cholesterol, combined with sluggish gallbladder emptying and changes in the gallbladder wall such as inflammation and mucin buildup.¹⁷ But the story goes beyond the gallbladder itself. Insulin resistance, obesity, metabolic syndrome, and type 2 diabetes all promote gallstone formation, as do genetic factors, hormonal influences, slow intestinal motility, and shifts in the gut microbiome.¹⁸ High blood cholesterol and high LDL levels are associated with higher rates of cholesterol-rich gallstones, while low HDL alone does not seem to have the same effect.¹⁹

Many gallstones remain silent and are only discovered incidentally during imaging for something else. When they do cause symptoms, the classic presentation is biliary colic: sudden intense pain in the upper right abdomen, often after a fatty meal, sometimes radiating to the back or shoulder. Complications include inflammation of the gallbladder, blockage of the bile duct, and, rarely, pancreatitis.

Fatty Liver Disease

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called non-alcoholic fatty liver disease (NAFLD), has become one of the fastest-growing digestive conditions in the world. Global incident cases of MASLD-related chronic liver disease nearly doubled between 1990 and 2021, rising from about 25 million to more than 48 million new cases per year.²⁰ In the United States, modeling estimates that about a third of adults had MASLD in 2020, and that figure is projected to rise to over 40% by 2050.²¹

The more advanced inflammatory form of the disease, known as MASH (metabolic dysfunction-associated steatohepatitis), is where the real danger lies. MASH can progress to significant scarring, cirrhosis, liver cancer, and liver failure. The same U.S. projections estimate that liver-related deaths from MASLD could roughly triple between 2020 and 2050, from about 30,500 to 95,300 annually.²¹ This trajectory is closely tied to rising rates of obesity, type 2 diabetes, and metabolic syndrome.

Chronic Pancreatitis

The pancreas tends to get less attention than the stomach or liver, but chronic pancreatitis is a serious and debilitating digestive disease. It involves progressive inflammation and scarring that gradually destroys the gland’s ability to produce digestive enzymes and regulate blood sugar. The two most prominent risk factors are heavy alcohol use and smoking, though genetic predisposition and other causes are increasingly recognized.²²

People with chronic pancreatitis typically suffer from persistent upper abdominal pain, weight loss, and greasy or foul-smelling stools caused by poor fat absorption. Over time, the disease frequently leads to diabetes (specifically type 3c, caused by pancreatic damage rather than the usual autoimmune or metabolic pathways) and complications like bile duct narrowing. Because the pancreas can no longer properly break down and absorb nutrients, patients are also at higher risk for osteoporosis and fractures from vitamin deficiencies.²²

How Diet and the Microbiome Connect These Conditions

A thread running through many of the diseases above is the gut microbiome. When the community of intestinal bacteria falls out of balance, it can contribute to chronic inflammation that feeds into IBD, obesity, and even cancer.²³ What you eat has a powerful effect on whether those microbial communities stay healthy. Diets high in ultra-processed foods, which are loaded with synthetic additives and emulsifiers while being low in fiber, are associated with reduced microbial diversity, fewer beneficial bacterial species, and higher levels of pro-inflammatory organisms. These shifts have been linked to metabolic syndrome, IBS, type 2 diabetes, and colorectal cancer.²⁴

Ultra-processed foods also tend to be low in fiber and essential nutrients, compounding the damage to gut health beyond just the additives they contain.²⁵ Fiber is not just “roughage” to keep things moving. It feeds the beneficial bacteria that produce short-chain fatty acids, which help maintain the intestinal lining and regulate inflammation. A diet chronically low in fiber starves those populations and shifts the microbiome toward a state that promotes disease.

Infections That Leave Lasting Gut Problems

Not all digestive disease is chronic from the start. Infections can trigger long-term gut dysfunction even after the original pathogen is cleared. One of the best-documented examples involves Clostridioides difficile, a bacterium that causes severe diarrhea and colitis, usually after antibiotic use disrupts normal gut flora. Up to a quarter of patients who recover from a C. difficile infection go on to develop functional symptoms resembling post-infectious IBS.²⁶

Animal research backs this up: mice that recovered from C. difficile infection showed slower intestinal transit and signs of a constipation-like pattern weeks after the acute infection had resolved, and the severity of initial inflammation predicted the degree of long-term gut dysfunction.²⁷ The practical takeaway is that if you develop new, persistent gut symptoms after recovering from a serious intestinal infection, it is worth discussing with a doctor rather than assuming the infection simply wasn’t fully treated.

Colorectal Cancer Screening

Colorectal cancer is the digestive malignancy most amenable to screening, and early detection makes a dramatic difference. Screening catches tumors at earlier stages, which directly improves survival rates and reduces treatment costs.²⁸ In the United States, guidelines now recommend that average-risk adults begin screening at age 45, down from the previous threshold of 50, a shift driven by rising incidence in younger adults. Options include colonoscopy, stool-based tests like the fecal immunochemical test (FIT), and newer stool DNA tests. The “best” screening test is often whichever one you will actually complete, since the biggest barrier remains people skipping screening altogether.

Gut-Directed Hypnotherapy and Behavioral Treatments

For conditions like IBS and functional dyspepsia, where the gut-brain connection plays a central role, behavioral treatments are gaining evidence and clinical traction. Gut-directed hypnotherapy, which uses focused relaxation and guided imagery targeting digestive function, has shown results comparable to the low-FODMAP diet for IBS. In a randomized trial, about 72% of patients in both the hypnotherapy and the dietary groups reported meaningful symptom improvement, and those gains held at six months after treatment ended.²⁹ Hypnotherapy also outperformed the diet on psychological measures like anxiety and depression, which frequently co-occur with IBS and worsen symptoms.

For functional dyspepsia, the evidence is more preliminary but encouraging. Several studies have reported improvements in symptoms, and patients often describe broader benefits in physical and mental well-being, though more randomized trials are needed before the approach can be recommended with the same confidence as for IBS.³⁰ The broader point is that digestive disease treatment is moving beyond pills and dietary restrictions. For functional conditions driven by the gut-brain axis, training the brain’s side of the conversation can be just as effective as targeting the gut.

1
Gastroenterology. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
2
PubMed Central. Global, regional, and national burden of 10 digestive diseases in 204 countries and territories from 1990 to 2019
3
BMJ. Persistent health inequality in the global burden of digestive diseases attributable to risk factors: a systematic analysis for the Global Burden of Disease Study 2021
4
PubMed Central. Irritable bowel syndrome, the microbiota and the gut-brain axis
5
PubMed Central. Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment
6
PubMed Central. Exploring Clinical Similarities and Distinctions Between Gastroparesis and Functional Dyspepsia: A Propensity-Matched Cohort Study
7
PubMed Central. Age at onset of GERD symptoms predicts risk of Barrett’s esophagus
8
PubMed Central. Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights
9
PubMed Central. Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer Disease
10
PubMed Central. Comparative study on the pathogenesis of Crohn’s disease and ulcerative colitis
11
PubMed Central. Epidemiology and risk factors for diverticular disease
12
International Journal of Clinical and Experimental Medical Sciences. Prevalence of Human Hemorrhoid and Overview of Medicinal Plants with Anti-Hemorrhoidal Potential
13
PubMed Central. Hemorrhoids: from basic pathophysiology to clinical management
14
European Journal of Gastroenterology & Hepatology. Functional constipation in patients with hemorrhoids: a systematic review and meta-analysis
15
PubMed. Celiac disease: from gluten to autoimmunity
16
PubMed Central. Clinical and Histologic Mimickers of Celiac Disease
17
PubMed Central. An update on the pathogenesis of cholesterol gallstone disease
18
PubMed Central. Recent advances in understanding and managing cholesterol gallstones
19
PubMed Central. The effects of serum cholesterol, LDL, and HDL levels on gallstone cholesterol concentration
20
PubMed Central. The burden of NAFLD-related chronic liver disease and cirrhosis from 1990 to 2021 with projections to 2036: a comparative study of global China the United States and India
21
JAMA Network Open. Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050
22
Medicine. Pancreas Chronic pancreatitis and exocrine pancreatic insufficiency
23
PubMed Central. Impacts of gut bacteria on human health and diseases
24
PubMed Central. The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier
25
Future Foods. The potential hazards of ultra-processed foods on gastrointestinal health
26
PubMed. Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment
27
PubMed Central. Clostridioides difficile Infection Promotes Gastrointestinal Dysfunction in Human and Mice Post-Acute Phase of the Disease
28
PubMed Central. Colorectal cancer screening: The value of early detection and modern challenges
29
PubMed. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome
30
American Journal of Therapeutics. The Efficacy of Hypnotherapy in the Treatment of Functional Dyspepsia